40 percent of Americans belong to a minority racial or ethnic group, yet only 2 percent of cancer clinical trials have studied enough minorities to provide useful information to these populations. In this webinar Dr. Susan Love, from the Dr. Susan Love Research Foundation, presents on the importance of including communities of color in breast cancer research, the barriers to diversifying research, and what can be done to address them.
Bhawanipatna Call Girls 📞9332606886 Call Girls in Bhawanipatna Escorts servic...
Communities of Color and Participation in Breast Cancer Research
1. BREAST CANCER IN WOMEN OF
COLOR:
IT’S COMPLICATED
DR. SUSAN LOVE RESEARCH
FOUNDATION
Susan M Love, MD, MBA
Chief Visionary Officer,
Dr. Susan Love Research Foundation
3. OLAPADE 2015
WOMEN OF COLOR: THE PERFECT STORM
Differences in tumor biology and genomics
plus
Differences in patterns of care
equals
Breast cancer mortality gap
4. INCIDENCE AND DEATH RATESBREAST CANCER IN AFRICAN AMERICANS IS MORE DEADLY BUT
NOT IN HISPANIC WOMEN OR ASIAN/PACIFIC ISLANDERS
Death rates, however,
are higher
Incidence rates in AA women
are similar to other races and
ethnicities
5. ALTHOUGH THERE IS SOME IMPROVEMENT IN MORTALITY, THERE
ARE STILL LAGS OVER OTHER ETHNIC GROUPS
8. THE DEATH RATE IS HIGHER?
African American women are
more likely to die of breast
cancer than Caucasian women
at every age
• Why
• Less access to screening mammography
• Less access to state of the art care
• Biology
• Lifestyle
• ???
Newman JAMA Oncology
2017
12. LOS ANGELES COUNTY
PER CENT BREAST CANCER CASES DIAGNOSED AT EARLY
STAGE
LATE DETECTION OR ACCESS TO CARE
non Hispanic whites 3,398 (72.6%)
African American 857 (64.9%)
Hispanic 2,069 (65.3%)
Asian/Pacific Islander 1,300 (69%)
Race
all races 80%
NH whites 80%
NH Blacks 87%
age 45-65 79%
age over 65 82%
no med care 47%
no insurance 50%
ACCESS TO CARE
13. BRCA 1/2
IS IT BE HEREDITARY ?
Northern California Breast Cancer Family Registry showed BRCA 1
mutation is 16.7% in African American Cases diagnosed under 35 and
7.2% in non Hispanic Jewish whites
• But in a study by Armstrong et al , AA women with a family
history of breast or ovarian cancer were (1/5 as often)
significantly less likely than white women to receive testing or
counseling regarding BRCA1/2 testing
Hispanic women of Mexican descent have been found to carry
hereditary mutations
• 35 mutations were identified in 3.4% including BRCA 1 and 2.
Only 5/34 had a family history
14. Term Latina or Hispanic Can Cover Several Ethnic/Racial Groups
LATINA GENETICS ARE COMPLICATED
15. COULD THERE BE AN AFRICAN MUTATION?
TRIPLE NEGATIVE BREAST CANCER IS MORE OFTEN GENETIC
Ghana
African American
17. • Mammography process is broken with quality differences in the
manner in which centers provided care and reported results Ansel
et al 2009
• Delays in treatment 29.2 days AA vs 22.5 days for NHW
• African American women not receiving guideline concordant
treatment (19%-11%)
• Under treated
• Not enrolled in clinical trials
• Comorbidity such as obesity
QUALITY OF CARE
18. SOLUTIONS
QUALITY OF CARE
• Insurance
• Patient education and physician communication
• Patient navigation
• System change
• “Interventions aimed at health care system improvement are few, with the responsibility for
change resting with the patient rather than the care delivery system. “
• “The majority of interventions failed to involve major stakeholders, including providers,
health care institutions, its organizers and policy makers and accordingly were unlikely to
succeed in creating meaningful change. “
“successful strategies for reducing health disparities, are culturally tailored to meet
patient’s needs, employ multidisciplinary teams of care providers and target multiple
leverage points along a patients’s pathway of care. “Chin et al
19. ARE THERE OTHER FACTORS?
•
•
•
• Biology
• Subtype
• Age
• Hereditary
• Lifestyle
• Lactation
• Obesity
• Stress
ARE THERE OTHER FACTORS?
20. SUBTYPES OF BREAST CANCER
BIOLOGY: SUBTYPE
There are four molecular markers that we use to differentiate the biology of breast
cancer into three groups:
Luminal A and B (hormone positive): estrogen receptor +, progesterone receptor +
HER 2 positive: epidermal growth factor over expressing
Triple negative (basal): estrogen receptor -, progesterone receptor -, HER2 -
27. INVOLUTING BREAST MORE CANCEROGENIC
• Women who breast feed have less
breast cancer
• AA women less likely to breast feed
• Involution biology is tumorigenic
• NSAIDS can reduce risk
33. MORE RESEARCH
HOW WILL WE SORT THIS OUT?
We need to study all women
and men with breast cancer!
We need to study ALL stages of
breast cancer from in situ to
metastatic disease!
We need to move from
mice to people!
The only way to have the
research represent ALL of us, is
to have everybody participate!
Sign up at ArmyofWomen.org
34. THE ARMY OF WOMEN NEEDS YOU!
TO HELP US REPRESENT ALL WOMEN
35. SIGN UP AT WWW.ARMYOFWOMEN.ORG
HOW THE ARMY OF WOMEN WORKS
Eblasts: Be the first to hear about studies recruiting with the
Army of Women
Current Studies: Learn about all Army of Women supported
research studies
Webinars: Listen to researchers discuss their studies and
results
Your Impact: See how your support has changed the face
of breast cancer research
36. HELP ANSWER THE QUESTIONS BY
PARTICIPATING IN RESEARCH YOURSELF!
COMMIT TO LOVE!